Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > Downstream Processing

Repligen CEO says Spectrum acquisition fills gap in bioprocessing product line

27-Jun-2017 - Repligen Corporation has announced it will acquire filtration-focused Spectrum Pharmaceuticals for approximately $350m (€312m).

Protein A resin maker teams on continuous and column-free chromatography tech

23-Jun-2017 - ChromaTan will incorporate Purolite’s Protein A beads into its continuous platform in a move the firms say will up productivity by 15 times over conventional batch chromatography.

Sanofi outlines €600m biologics manufacturing investment plan

16-Jun-2017 - Sanofi has said it will spend €600m ($673m) to increase capacity to make biologic drugs over the next three years.

Keeping it in the family: Rentschler to offer fill and finish services

13-Jun-2017 - Rentschler Biotechnologie has entered into a strategic partnership with Rentschler Fill Solutions to offer its clients aseptic fill and finish services.

Update - BioMarin to hire 50 people at Shanbally

US FDA clears BioMarin to make $380,000-a year Vimizim in Ireland

12-Jun-2017 - The US FDA has cleared BioMarin Pharmaceutical Inc. to make the enzyme replacement drug Vimizim (elosulfase alfa) at its plant in Cork, Ireland.

Takeda breaks ground on $45m Ninlaro plant in Ireland

06-Jun-2017 - Takeda has begun construction of an Irish facility to support production of its orally delivered blood cancer peptide Ninlaro (ixazomib).

LSNE tapped for drug substance manufacturing, fill/finish services

25-May-2017 - LSNE Contract Manufacturing has signed a manufacturing supply agreement with Selecta Biosciences, Inc. through which the CDMO will advance Selecta’s lead candidate, SEL-212.

Amgen: Bioprocess intensification and integration key for next-generation manufacturing

23-May-2017 - Its new Singapore single-use plant is a fraction of the size of a conventional commercial facility but next-generation biomanufacturing at Amgen points to even smaller, more integrated sites.

Industry 4.0 making its mark in biomanufacturing sector, Thermo Fisher

10-May-2017 - Integrating single-use, automation and continuous processing equipment will be the future for bioproduction says Thermo Fisher acquisition Finesse Solution.


Continuous chromatography and single-use filtration at BPI Europe

03-May-2017 - Pall Corporation, GE Healthcare and LEWA Process Technologies showed off their latest downstream offerings to Biopharma-Reporter in Amsterdam last week.

GSK to ship malaria vaccine for African pilot programme

28-Apr-2017 - GSK says maintaining an unbroken cold chain will be critical as it prepares to rollout malaria vaccine pilot programme. 

Filtration is a ‘high value process at a marginal cost,’ says Danaher

25-Apr-2017 - Danaher reported mid-single-digit growth from its bioprocessing subsidiary Pall Life Science and expects a continued trajectory to support Biopharma’s filtration needs.

MilliporeSigma launches M-pleat pattern single-use filters

14-Apr-2017 - MilliporeSigma has launched a range of high area cartridges and single use capsules it says gives biomanufacturers greater efficiency in the filtration step.

GE aiming to be cell therapy production services one-stop-shop

12-Apr-2017 - GE Healthcare has acquired cryopreservation technology firm Asymptote and says more investments are likely as it builds an “end-to-end ecosystem” for cellular therapy production services.

Automation acquisitions 'capture the future of streamline production,' expert

12-Apr-2017 - There is a growing trend among vendors to integrate automation technologies into their offerings says a bioprocessing expert, as GE Healthcare invests in its partner Zenith.

Sumitomo Dainippon buys cell therapy processing tech from Hitachi

10-Apr-2017 - Sumitomo Dainippon Pharma Co Ltd has ordered cell culture technologies from Hitachi as part of its effort to develop a treatment for Parkinson’s disease.

Selling cell thawing: Medcision launches early adopter scheme to push tech

07-Apr-2017 - Medcision has started pushing its cell therapy thawing technology through an early adopter scheme designed to encourage adoption by firms with candidates in trials.

News in brief

Permira to buy Lyophilization Services of New England

28-Mar-2017 - Private equity fund Permira has announced its intention to buy freeze drying firm Lyophilization Services of New England Inc (LSNE) 

Lilly: Tax reforms would release $150m to further support US manufacturing

27-Mar-2017 - Eli Lilly will invest $850m in its US operations this year but warns the country’s antiquated tax system leaves the firm at a competitive disadvantage.

Roquette aims to up its biologic reagent presence

17-Mar-2017 - Roquette says investments in packaging, documentation and testing requirements have helped the firm move into the biologics excipient and reagent space.

Patheon: Biologics seeds to bloom in 2018 as products shift to commercial

17-Mar-2017 - Patheon says it expects to see a surge in biologics revenue in 2018 as products shift from development stage to commercial.

GE Healthcare installs purification tech at FujiFilm Diosynth site

15-Mar-2017 - GE Healthcare has completed another tech installation at FujiFilm Diosynth’s biopharmaceuticals facility in Billingham, UK, integrating a single-use purification system with bioreactors it provided in 2014.

Repligen to up column production on back of ‘milestone year for chromatography’

08-Mar-2017 - Repligen will boast seven packing suites for its range of OPUS chromatography columns by the end of the month, up from two this time last year.

Biocon's second fill/finish line at Bangalore site to come online later this year

Mylan and Biocon Neulasta biosimilar to go under US FDA scrutiny

17-Feb-2017 - Biocon’s biomanufacturing facilities in India will need a “meaningful capacity expansion” to cope with long-term global biosimilar demand, the firm says.

Sanofi awaits FDA inspection of fill/finish plant before Q1 Kevzara resubmission

09-Feb-2017 - Sanofi intends to resubmit its licensing application for Kevzara within the next few weeks following subject to a US FDA re-inspection of a French fill/finish plant.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...